Ce-Duox1/BLI-3 generates reactive oxygen species as a protective innate immune mechanism in Caenorhabditis elegans.
Caenorhabditis elegans was recently developed as a model system to study both pathogen virulence mechanisms and host defense responses. We previously demonstrated that C. elegans produces reactive oxygen species (ROS) in response to exposure to the important gram-positive nosocomial pathogen Enterococcus faecalis. We also presented evidence of oxidative stress and upregulation of stress responses after exposure to the pathogen. As in mammalian systems, this new work shows that production of ROS for innate immune functions occurs via an NADPH oxidase. Specifically, reducing expression of a dual oxidase, Ce-Duox1/BLI-3, causes a decrease in ROS production in response to E. faecalis. We also present evidence that reduction of expression of Ce-Duox1/BLI-3 increases susceptibility to this pathogen, specifically when expression is reduced in the intestine and the hypodermis. Ce-Duox1/BLI-3 was previously characterized as having a role in cuticle cross-linking. Two C. elegans mutants with point mutations in the peroxidase domain that exhibit severe cuticle defects were discovered to be unaffected in ROS production or pathogen susceptibility. These results demonstrate an important biological role for the peroxidase domain in cuticle cross-linking that is unrelated to ROS production. To further demonstrate the protective effects of the pathogen-induced ROS production, we show that antioxidants that scavenge ROS increase the sensitivity of the nematode to the infection, in stark contrast to their longevity-promoting effects under nonpathogenic conditions. In conclusion, we postulate that the generation of ROS by NADPH oxidases in the barrier epithelium is an ancient, highly conserved innate immune defense mechanism.
Chávez
Violeta
V
Department of Microbiology and Molecular Genetics, The University of Texas Health Science Center at Houston, 6431 Fannin St./MSB 1.168, Houston, TX 77030, USA.
Mohri-Shiomi
Akiko
A
Garsin
Danielle A
DA
D000818:Animals; D017173:Caenorhabditis elegans / Q000276:immunology*; D029742:Caenorhabditis elegans Proteins / Q000096:biosynthesis / Q000276:immunology*; D000074623:Dual Oxidases; D016908:Gram-Positive Bacterial Infections / Q000276:immunology*; D006790:Host-Parasite Interactions / Q000276:immunology*; D007113:Immunity, Innate; D019255:NADPH Oxidases / Q000096:biosynthesis / Q000276:immunology*; D010088:Oxidoreductases; D017382:Reactive Oxygen Species / Q000276:immunology*
D029742:Caenorhabditis elegans Proteins; D017382:Reactive Oxygen Species; C544706:Bli-3 protein, C elegans; D010088:Oxidoreductases; D000074623:Dual Oxidases; D019255:NADPH Oxidases
FASEB J. 2003 Aug;17(11):1502-4
12824283
J Biol Chem. 2004 Aug 27;279(35):36454-61
15210697
J Immunol Methods. 1997 Mar 28;202(2):133-41
9107302
Pharmacol Biochem Behav. 2006 Nov;85(3):620-8
17156833
Nature. 2003 Jan 16;421(6920):231-7
12529635
J Leukoc Biol. 2004 Oct;76(4):760-81
15240752
Mech Ageing Dev. 2005 Jun-Jul;126(6-7):642-7
15888317
Free Radic Biol Med. 2009 Feb 1;46(3):414-21
19061950
Curr Biol. 2008 Apr 8;18(7):481-9
18394898
Am J Respir Cell Mol Biol. 2003 Aug;29(2):206-12
12626341
FEBS Lett. 2005 Aug 29;579(21):4911-7
16111680
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10892-7
11535834
Dis Model Mech. 2008 Nov-Dec;1(4-5):205-8
19093025
FASEB J. 2009 Apr;23(4):1205-18
19074510
Cell Microbiol. 2005 Jun;7(6):741-51
15888078
PLoS Biol. 2003 Oct;1(1):E12
14551910
Biochemistry. 1982 Feb 2;21(3):562-7
7066307
J Gen Physiol. 2005 Oct;126(4):379-92
16186564
Science. 2005 Nov 4;310(5749):847-50
16272120
Dev Cell. 2009 Mar;16(3):386-97
19289084
Genome Biol. 2001;2(1):RESEARCH0002
11178279
Physiol Rev. 2007 Jan;87(1):245-313
17237347
J Biol Chem. 2008 Jan 4;283(1):194-201
17951251
Science. 2003 Jun 20;300(5627):1921
12817143
Gene. 2007 Oct 1;400(1-2):166-73
17681718
Immunol Res. 2009;43(1-3):198-209
18979077
Biochim Biophys Acta. 1996 Dec 13;1304(3):210-22
8982267
Genetics. 1999 Jun;152(2):783-95
10353918
Science. 2000 Oct 27;290(5492):809-12
11052945
Biochim Biophys Acta. 1966 Mar 28;117(1):63-72
4380562
Gen Pharmacol. 1997 Sep;29(3):315-31
9378235
Curr Biol. 2004 Jun 8;14(11):1018-24
15182677
J Biol Chem. 2009 Jul 10;284(28):18634-43
19460756
J Biol Chem. 2006 Jul 7;281(27):18269-72
16651268
J Immunol. 1963 Jan;90:12-6
14003407
J Cell Biol. 2001 Aug 20;154(4):879-91
11514595
RNA. 2001 Oct;7(10):1397-402
11680844
Genetics. 1974 May;77(1):71-94
4366476
Science. 2002 Jul 26;297(5581):623-6
12142542
Free Radic Biol Med. 2007 Aug 1;43(3):319-31
17602947
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2735-9
11226309
Genetics. 2007 Jul;176(3):1567-77
17483415
Nat Rev Immunol. 2004 Mar;4(3):181-9
15039755